Home/Pipeline/ELX‑02

ELX‑02

Cystic Fibrosis (nonsense mutations)

Phase 1Active

Key Facts

Indication

Cystic Fibrosis (nonsense mutations)

Phase

Phase 1

Status

Active

Company

Eloxx Pharmaceuticals, Eloxx Pharmaceuticals, Eloxx Pharmaceuticals

About Eloxx Pharmaceuticals

Ribosome‑targeted small‑molecule platform for rare genetic diseases and cancer.

View full company profile

About Eloxx Pharmaceuticals

Ribosome‑targeted small‑molecule platform for rare genetic diseases and cancer.

View full company profile

About Eloxx Pharmaceuticals

Ribosome‑targeted small‑molecule platform for rare genetic diseases and cancer.

View full company profile

Therapeutic Areas

Rare Genetic Diseases Oncology